Purpose: Inflammatory cells are known to be associated with the progression of atherosclerosis and plaque rupture. However, the relation to inflammatory cells and apolipoproteins on the progression of atherosclerosis is unknown. This study was aimed at examining the different expressions of inflammatory cells and evaluate the effect of apolipoprotein (APO) C1 and APO E during the progression of atherosclerosis. Methods: Ten atherosclerotic tissues were compared with five non-atherosclerotic tissues. The presence of vascular smooth muscle cells (VSMCs), macrophages, T-cells, APO C1, and APO E were identified by Western blotting and immunohistochemical analysis with antibodies. The senescence was analyzed by senescence-associated β-galactosidase. Results: The protein expression and senescence of macrophages, APO C1 and APO E were significantly higher in the main atherosclerotic lesion than the non-atherosclerotic lesion. A high concentration of inflammatory cells and the paucity of VSMCs were present in the shoulder area. In addition, macrophage and T-cells are expressed in the early stage of atherosclerotic development and more expanded in advanced atherosclerotic plaques. APO C1 was expressed mainly within the necrotic core, and APO E existed mostly around the necrotic core and the fibrous cap in advanced atherosclerotic plaques. Conclusion: Our study indicated that the expression and the senescence of macrophage and T-cells may be closelyrelated to induction and deposition of APO C1 and APO E. This contributes to the development and progression of atherosclerotic plaque by expanding the necrotic core.
INTRODUCTION
Atherosclerosis is understood recently to be an inflammatory process that involves the infiltration of inflammatory cells and complex structures that consists of smooth muscle cells, macrophages, lymphocytes, microvessels and different types of collagen [1] [2] [3] [4] . It is known that the major cell types of inflammatory cells are macrophages and T-lymphocytes which are closely associated with plaque rupture [5] . In addition, vascular smooth muscle cells (VSMCs) proliferation has been identified in early atherosclerotic lesions. This is in contrast to the low level proliferation of VSMCs detected in advanced lesions, which suggests that the VSMCs might be senescent, as demonstrated by the senescence-associated β-galactosidase (SAβG) activity [1, 2, 6] .
As the atherosclerosis progresses, the VSMCs become a senescent and undergo the apoptosis [7, 8] . The apoptotic thesurgery.or.kr cells were found in areas near or within the lipid rich core, and the apoptosis of VSMCs is associated with the remodeling and stability of atherosclerotic plaque [9, 10] . In critical regions of the plaque, the apoptosis of VSMCs predisposes the plaque to rupture and subsequent thrombosis [11] .
The interaction between apoptotic VSMCs and inflammatory cells, such as macrophages and T-lymphocytes, leads to the thinning of the fibrous cap overlying the lipid-rich core and this contributes to plaque rupture. It has been known that apolipoprotein (APO) C1 and APO E are expressed in macrophages and most of the expressed genes induced by macrophage colony-stimulating factor were identified to be APO C1 and APO E [12, 13] . Further, the expression of APO C1 is highly correlated with an APO E expression [12] . The expressed macrophage and T-cells may affect the degradation of the extracellular matrix and the depletion of VSMCs, which are both seen in the development of atherosclerosis. We have previously reported that APO C1 and APO E were prominently expressed in carotid atherosclerotic lesions, as compared to non-atherosclerotic arteries [14] .
In the present study, we compared the regional differences of the expressions and senescence of cellular components, such as VSMCs, cluster of differentiation 68 (CD68, macrophage), CD3 (T-lymphocyte), APO CI, and APO E, in atherosclerotic lesions. In addition, we identified that the expression of cellular components in less advanced atherosclerotic plaques by comparing more advanced atherosclerotic plaques. 
METHODS

Specimens
Western blot analysis
SAβG staining
The SAβG activity was determined by using a SAβG mmol/L MgCl2, 0.01% sodium deoxycholate and 0.02% Nonidet-40. The 10 μm-thick formalin-fixed, paraffin-embedded sections were then subjected to immunohistochemistry.
Immunohistochemistry
After deparaffinization followed by dehydration, the serial paraformaldehyde-fixed paraffin sections were Fig. 1A) arteries.
In the main lesion of the atheroma (lanes 5 & 6 in Fig. 1A and ⓐ lesion in Fig. 1B) , CD68, hTERT, APO C1 and APO E were more prominently expressed than the adjacent area (lane 7 in Fig. 1A and ⓑ lesion in Fig. 1B ).
Cellular senescence and inflammatory cells in the shoulder area of atherosclerotic plaques
β-galactosidase (β-gal) activity, which is known as a senescence marker of atherosclerosis, was represented in the carotid atherosclerotic plaque (green area in Fig. 2A-2) but not in the non-atherosclerotic artery ( Fig. 2A-1) . In addition, VSMCs, macrophages and T-lymphocytes were expressed in the media of the β-gal stained areas (Fig. 2B-3 (2)). (B) The serial sections of the luminal layer of endarterectomized carotid atheroma stained for β-gal activity and immunohistochemistry stains for α-smooth muscle actin (3), CD3 (4), and CD68 (5). The (3), (4), and (5) were doble stained with β-gal and each antibody. The results were the same for experiment five (Magnification: ×40 for (3), (4), and (5); ×200 for (3-1), (4-1), and (5-1)). compared with the number of macrophages and T-lymphocytes. The expression of T-lymphocytes was more prominent in the β-gal stained area, as compared with the non-stained area (Fig. 2B-4, 4-1) .
Expression of inflammatory cells and apolipoproteins in the 'focal' and 'diffuse' atherosclerotic plaques
The sites of critical stenosis were retrieved from the endarterectomy specimens. Atherosclerotic plaques in critical stenosis were divided into 'focal' and 'diffuse' athero-thesurgery.or.kr (Fig. 3) . The histological examination revealed that the number of VSMCs was higher in the focal atherosclerotic plaques than that in the non-atherosclerotic artery (Fig. 3) . Macrophages and T-lymphocytes expressed in the focal and diffuse atherosclerotic lesions, but not in the non-atherosclerotic arteries. In addition, the expression of inflammatory cells was more prominent in the shoulder area of the focal lesions (arrow in Fig. 3) . The expressions of APO C1 and APO E were showed in the focal and the diffuse lesions, but not in the non-atherosclerotic arteries (Fig. 3) . In the diffuse lesion, macrophages were prominently expressed in the fibrous cap. Moreover, APO E was mainly represented in the regions around the necrotic core and fibrous cap, and APO C1 was mainly demonstrated within the necrotic core.
DISCUSSION
The development of atherosclerosis is induced by the migration, proliferation and differentiation of inflammatory cells, mainly macrophages and T-lymphocytes.
The monocytes differentiate into macrophages in the vessel wall and the macrophages produce various proteases that degrade the extracellular matrix [15] . Our study found that there was a high expression of macrophages in the main lesion of atherosclerotic plaques as compared with that of the area adjacent to the main lesion, as was assessed by Western blot analysis (Fig. 1A) . Macrophages express APO E, which has an anti-proliferative effect on VSMCs [16] . APO E null mice have been extensively used as an animal model for atherosclerosis as these mice develop atherosclerosis that is similar to that found in human [17, 18] . In addition, it has been previously reported that hTERT-APO E doubly deficient mice show impaired proliferation of both lymphocytes and macrophages, and reduced atherosclerosis [19] . However, we found that APO E and hTERT were more highly expressed in atherosclerotic lesions than in non-atherosclerotic arteries (Fig. 1A) . This finding suggested that the expressions of APO E and hTERT in atherosclerotic plaque may be affected by the proliferation of macrophages during the development of atherosclerosis. Also, we suppose that the difference of expression for these proteins in a same atherosclerotic patient may be the important causes to the presence of atherosclerotic lesion.
The expression of APO C1 is highly correlated with the APO E expression, and this is probably the result of their close location in the APO E/C1/C4/C2 gene cluster [8] . We found that APO C1 and APO E were overexpressed in atherosclerotic lesions, as compared with that of non-atherosclerotic arteries, by performing Western blot analysis (Fig. 1A) .
Foam cells of a macrophage origin, as indicated by immunoreactivity for CD-68, kill the adjacent VSMCs in the atherosclerotic plaque and the rupture sites are also characterized by the paucity of VSMCs and the high concentration of macrophages and inflammatory cells [20] [21] [22] .
Our histologic examinations indicated that there were high concentrations of macrophages and T-lymphocytes and the loss of VSMCs in the shoulder area and this area is known to be prone to plaque rupture [9] . This study, we showed that the loss of VSMCs and the prominent expression of macrophages during the progression of atherosclerosis (Fig. 3) .
β-gal staining is a useful marker for cellular senescence in both in vitro and in vivo because β-galactosidase is a metabolic enzyme that is highly expressed in senescent cells. Macrophages and T-lymphocytes are known to be major cell types that found at sites of rupture [7] and, in the present study, the senescence of these cells and the lack of VSMCs were observed in the shoulder area of atherosclerotic plaques (Fig. 2) . Our findings showed that large lipid-rich necrotic core were present in the 'diffuse' atherosclerotic lesions and this is resulted of increased apoptosis and decreased scavenging, which characterizes more advanced atherosclerotic plaque. APO C1 and APO E were highly expressed in the 'focal' and 'diffuse' atherosclerotic plaques, as compared with that in the non-atherosclerotic arteries. In particular, macrophages were prominently in the fibrous cap, APO C1 was mainly expressed within the necrotic core and APO E was particularly expressed around the necrotic core and fibrous cap in more advanced atherosclerotic plaques (Fig. 3) . These findings suggest that APO C1 and APO E are strongly associated with the expansion of necrotic core during the progression of atherosclerosis.
In conclusion, our findings represent that expression and senescence of macrophage and T-cells involved in the progression of atherosclerosis and suggest that expression and deposition of APO C1 and APO E contributes to the destabilization of atherosclerotic plaque by expanding the necrotic core. Therefore, the inhibition of macrophage, T-cells, the APO C1 and APO E may well become an increasingly important therapeutic strategy for preventing the progression of atherosclerosis.
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